Keyword Analysis & Research: frank vinluan medcity news
Keyword Research: People who searched frank vinluan medcity news also searched
Search Results related to frank vinluan medcity news on Search Engine
-
Frank Vinluan, Author at MedCity News
https://medcitynews.com/author/fvinluan/
WEBFrank Vinluan is senior biopharma reporter for MedCity News. He previously held business reporting positions at Xconomy, The Seattle Times, The Des …
DA: 85 PA: 40 MOZ Rank: 51
-
Frank Vinluan - Senior Biopharma Reporter - MedCity News - LinkedIn
https://www.linkedin.com/in/frankvinluan
WEBMedCity News. About. You know all those television commercials pitching the latest pill to relieve what ails you? I'm … Title: Senior Biopharma Reporter at MedCity News Connections: 500+ Location: 705 followers
Title: Senior Biopharma Reporter at MedCity News
Connections: 500+
Location: 705 followers
DA: 63 PA: 54 MOZ Rank: 37
-
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spann…
https://medcitynews.com/2024/04/boehringer-ingelheim-regenerative-medicine-mash-chronic-liver-disease-ai-ochre-bio/
WEB3 days ago · By Frank Vinluan on April 22, 2024. The liver is the only organ in the human body capable of regenerating itself. ... MedCity News Daily …
DA: 19 PA: 3 MOZ Rank: 83
-
Frank Vinluan’s Profile | MedCity News Journalist | Muck Rack
https://muckrack.com/frankvinluan
WEBVerified. Senior Biopharma Reporter, MedCity News. North Carolina. Business and Finance, Health, Science. As seen in: MedCity News, Xconomy, Above the …
DA: 91 PA: 2 MOZ Rank: 35
-
Novartis Pays $90M for Molecules That Could Take STING Out of
https://medcitynews.com/2024/03/novartis-pays-90m-for-molecules-that-could-take-sting-out-of-inflammation/
WEBMar 13, 2024 · By Frank Vinluan. Post a comment / Mar 13, 2024 at 1:47 PM. For more than four years, Novartis has foot the bill for a partner’s preclinical …
DA: 39 PA: 53 MOZ Rank: 57